Linked Life Data

18789513

Source:http://linkedlifedata.com/resource/pubmed/id/18789513

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2 Suppl
pubmed:dateCreated
2008-11-5
pubmed:abstractText
Pelvic and paraaortic lymph nodes are common sites of metastases from gynecologic malignancies and may act as a sanctuary of chemoresistant tumor cells in some patients. There is no doubt that the evaluation of the regional lymph nodes provides important prognostic information for patients with gynecologic malignancies. The rationale is a more accurate assessment of the extent of disease, allowing for better individualization of adjuvant therapy. Nonetheless, the therapeutic role of systematic lymphadenectomy in patients with gynecologic malignancies is still under debate. The retroperitoneal lymph node dissection (RPLND) has been shown to prolong survival for patients with chemorefractory ovarian immature teratoma. Furthermore, RPLND is an important aspect of post-chemotherapy debulking surgery for nonseminomatous germ cell tumors, which is the counterpart of the ovarian immature teratoma. Therefore, the ability to perform an extensive RPLND is an important skill in the surgical armamentarium of the gynecologic oncologist. In the following article we outline the surgical anatomy and describe the essential steps of the RPLND.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1095-6859
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
111
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S66-9
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Retroperitoneal lymph node dissection (RPLND).
pubmed:affiliation
Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
pubmed:publicationType
Journal Article